| Beyond Behavioral Health Llc | |
|
104 S Freya St Bldg Suite210 Spokane WA 99202-4862 | |
| (509) 964-1590 | |
| Not Available |
| Full Name | Beyond Behavioral Health Llc |
|---|---|
| Speciality | Counselor |
| Location | 104 S Freya St Bldg Suite210, Spokane, Washington |
| Authorized Official Name and Position | Angela M Mello (ADMINISTRATOR) |
| Authorized Official Contact | 5099641590 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Beyond Behavioral Health Llc 104 S Freya St Ste 210 Spokane WA 99202-4871 Ph: (509) 964-1590 | Beyond Behavioral Health Llc 104 S Freya St Bldg Suite210 Spokane WA 99202-4862 Ph: (509) 964-1590 |
| NPI Number | 1033728415 |
|---|---|
| Provider Enumeration Date | 07/30/2020 |
| Last Update Date | 08/18/2020 |
| Certification Date | 08/18/2020 |
| Medicare PECOS PAC ID | 3274951579 |
|---|---|
| Medicare Enrollment ID | O20200918001273 |
News Archive
A new, evidenced-based clinical practice guideline on molecular biomarker testing for patients with colorectal cancer identifies opportunities for improving patient outcomes.
Scientists at the Medical University of South Carolina (MUSC) have designed an antibody-based therapy that could target the functions of TGF-beta that cause cancer
A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs-many of which have already been introduced into clinical practice-that permit higher overall survival rates and improvements in the quality of life of cancer patients.
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033728415 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Secondary |
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Jason Edward Vestal |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851899215 PECOS PAC ID: 8820359235 Enrollment ID: I20180228000183 |
News Archive
A new, evidenced-based clinical practice guideline on molecular biomarker testing for patients with colorectal cancer identifies opportunities for improving patient outcomes.
Scientists at the Medical University of South Carolina (MUSC) have designed an antibody-based therapy that could target the functions of TGF-beta that cause cancer
A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs-many of which have already been introduced into clinical practice-that permit higher overall survival rates and improvements in the quality of life of cancer patients.
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
› Verified 9 days ago
| Provider Name | Angela Marie Mello |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1609171446 PECOS PAC ID: 4183042484 Enrollment ID: I20200921000827 |
News Archive
A new, evidenced-based clinical practice guideline on molecular biomarker testing for patients with colorectal cancer identifies opportunities for improving patient outcomes.
Scientists at the Medical University of South Carolina (MUSC) have designed an antibody-based therapy that could target the functions of TGF-beta that cause cancer
A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs-many of which have already been introduced into clinical practice-that permit higher overall survival rates and improvements in the quality of life of cancer patients.
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
› Verified 9 days ago
| Provider Name | Raymond G Fredrickson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1902495351 PECOS PAC ID: 4284001702 Enrollment ID: I20221111001900 |
News Archive
A new, evidenced-based clinical practice guideline on molecular biomarker testing for patients with colorectal cancer identifies opportunities for improving patient outcomes.
Scientists at the Medical University of South Carolina (MUSC) have designed an antibody-based therapy that could target the functions of TGF-beta that cause cancer
A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs-many of which have already been introduced into clinical practice-that permit higher overall survival rates and improvements in the quality of life of cancer patients.
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
› Verified 9 days ago
News Archive
A new, evidenced-based clinical practice guideline on molecular biomarker testing for patients with colorectal cancer identifies opportunities for improving patient outcomes.
Scientists at the Medical University of South Carolina (MUSC) have designed an antibody-based therapy that could target the functions of TGF-beta that cause cancer
A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs-many of which have already been introduced into clinical practice-that permit higher overall survival rates and improvements in the quality of life of cancer patients.
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
› Verified 9 days ago
Cynthea Cunninghamm Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 323 W 15th Ave, Spokane, WA 99203 Phone: 509-838-3221 | |
Pennyfarthing Applied Behavior Analysis Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 707 W 7th Ave Ste 200, Spokane, WA 99204 Phone: 509-850-1080 Fax: 509-461-2532 | |
C.r.e.w. Behavioral Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3928 N Howard St, Spokane, WA 99205 Phone: 509-862-0707 | |
Mide Integrative Therapies Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1516 W Riverside Ave Ste 208, Spokane, WA 99201 Phone: 707-337-6721 | |
New Perspectives Behavior, Pllp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 W Mission Ave Ste 245, Spokane, WA 99201 Phone: 509-590-0047 Fax: 509-590-1437 | |
Arc Professional Counseling Service Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6821 N Country Homes Blvd Ste 201, Spokane, WA 99208 Phone: 509-558-7559 | |
Inward Love Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9631 N Nevada St Ste 311, Spokane, WA 99218 Phone: 509-496-7439 |